Interestingly, Claudin-low breast tumors expressing high levels of RSK3 displayed increased TGFβ signaling (Fig. 5E), decreased cellular senescence (Fig. 5F) and decreased NF-κB (Fig. 5G) molecular signatures. The gene discussed is RPS6KA2; the disease is breast neoplasm.